Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 5:48 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 409–432 of 1,408 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cardiovascular Function Clear all

Conditions: Psoriasis
Interventions: 13N Amonia; Drug
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Hypertension, Aging
Interventions: Exercise, ACE inhibitor + exercise, Thiazide diuretic + exercise, Angiotensin receptor blocker + exercise; Behavioral · Drug
Lead sponsor: University of Florida; Other
Eligibility: 65 Years and older
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Hemiparesis, Stroke
Interventions: rTMS, BCI Training; Device · Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 70 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Atrial Fibrillation
Interventions: Dronedarone, Placebo (for Dronedarone); Drug
Lead sponsor: Sanofi; Industry
Eligibility: 21 Years and older
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 56
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Beverly Hills, California + 51 more

Conditions: Stroke, Physical Disability
Interventions: real stimulation, no stimulation; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Metabolic Syndrome, Vascular Injury, Ischemic Preconditioning, Endothelial Function (reactive Hyperemia), Endothelial Dysfunction
Interventions: Ischemic preconditioning, Intravenous lactate infusion, No ischemic preconditioning (control), Normal Saline Infusion (Placebo), Ischemic preconditioning and intravenous lactate; Procedure · Drug · Combination Product
Lead sponsor: Gary Van Guilder; Other
Eligibility: 18 Years to 65 Years
Enrollment: 68 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Gunnison, Colorado

Conditions: Peripheral Vascular Diseases
Interventions: Muscular Strength Training Group, Muscular Fitness Training Group; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 35 Years
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Estrogen, Cardiovascular Diseases, Microvasculature, Oral Contraceptive Use
Interventions: Nω-nitro-L-arginine methyl ester (L-NAME), Acetylcholine, Sodium Nitroprusside; Drug
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2031
U.S. locations: 1
States / cities: Wauwatosa, Wisconsin

Conditions: Peripheral Arterial Disease
Interventions: Pro-Omega, ProOmega Placebo; Dietary Supplement · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 50 Years to 100 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Obstructive Sleep Apnea
Interventions: Hypoglossal Nerve Stimulation Treatment Withdrawal; Device
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Cardiovascular Risk Factor
Interventions: No to Low Endogenous Estrogen, Estradiol; Other
Lead sponsor: University of Delaware; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Myocardial Deformation
Interventions: Fetal Echocardiogram; Other
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years to 64 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
Interventions: Atorvastatin 20 mg daily for 3 months; Drug
Lead sponsor: University of Florida; Other
Eligibility: 10 Years to 18 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Left Branch Bundle Block, RV - Right Ventricular Abnormality
Interventions: Pacemaker Interrogation and Electrocardiogram (ECG):, Cardiopulmonary Exercise Test (CPET) and Exercise Stress Cardiac Magnetic Resonance (ExeCMR, Continuous pacemaker telemetry (CPT); Other
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Autologous Hematopoietic Stem Cell Transplant
Interventions: RS-4i Plus Sequential Stimulator (RS Medical, Vancouver, WA); Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Cardiovascular Outcome, Overweight and Obese Women, Perimenopausal Women, Vasomotor Symptoms (VMS)
Interventions: Pork Diet, Plant Diet; Behavioral
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 40 Years to 55 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Spinocerebellar Ataxia
Interventions: Error-reduction, International Cooperative Ataxia Rating Scale, Scale for the Assessment and Rating of Ataxia, Beck Depression Inventory, 2nd Ed, Stroop, Purdue Pegboard, Brief Test of Attention, 6-minute Walk, Hand Grip Dynamometer, Montreal Cognitive Assessment, Physical Performance Function, Biomechanical Assessments of Dysmetria, Neurophysiological assessment of brain activity, Biomechanical gait analysis; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 21 Years to 85 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Obesity, Hypertension
Interventions: Angiotensin-(1-7), Saline; Drug
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Coronary Endothelial Dysfunction, Apical Ballooning Syndrome, Myocardial Infarction
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 190 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2011
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: HIV, Endothelial Dysfunction, Oxidative Stress
Interventions: PharmaNAC (N-acetylcysteine), Matching placebo; Dietary Supplement
Lead sponsor: Indiana University; Other
Eligibility: 50 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Stress Reaction
Interventions: Low-level laser therapy (LLLT); Other
Lead sponsor: Baylor University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Waco, Texas

Conditions: Heart Failure, Sedentary
Interventions: Regional Specific Training (RSTS); Other
Lead sponsor: Duke University; Other
Eligibility: 55 Years to 90 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2014
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Cardiovascular Disease
Interventions: Efavirenz, Rilpivirine; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Obesity, Pre-hypertension, Hypertension
Interventions: Whole Body Vibration Training, Hypocaloric diet, Whole body vibration training & diet; Other
Lead sponsor: Florida State University; Other
Eligibility: 45 Years to 65 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Tallahassee, Florida

Search by objective public record fields.

Effect of Chronic Inflammation on Myocardial Perfusion and Function

ACE Inhibitors Combined With Exercise for Seniors - Pilot Study

A Brain Centered Neuroengineering Approach for Motor Recovery After Stroke: Combined rTMS and BCI Training

Effects of Dronedarone on Cardiac Geometry and Function in Patients With Atrial Fibrillation and Left Atrial Enlargement

Smartwatch App for Vibration Stimulation

Therapeutic Strategies to Reduce Endothelial Ischemia-reperfusion Injury

Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 3

Estrogen and Microvascular Function

The Effects of Omega-3 Fatty Acids on Peripheral Arterial Disease II

Effect of Upper Airway Stimulation on Vascular Function in Obstructive Sleep Apnea

Menopause Effects on Vascular Function

Fetal Cardiac Strain Imaging Research

Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)

Functional Outcomes in CondUction System Pacing and Right Ventricular Synchrony (FOCUS-Right)

Muscle Stimulation for Physical Function During Stem Cell Transplant

Impact of Lean Pork on Endothelial Function in Perimenopause

Functional and Structural Imaging and Motor Control in Spinocerebellar Ataxia

Cardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension

The Relationship Between the Response to Mental Stress and Vascular Endothelial Function

N-acetylcysteine to Reduce Oxidative Stress and Improve Endothelial Function in HIV-infected Older Adults

Brain Substrates for Cardiovascular Stress Physiology

Heart Failure and Regional Specific Exercise Training Stimulus

Efavirenz Versus Rilpivirine on Vascular Function, Inflammation, and Oxidative Stress

Diet and Whole-body Vibration Training on Cardiovascular and Autonomic Function